NCT05675995

Brief Summary

The purpose of this study is to conduct a pilot feasibility study of a combination of external and internal qigong on health-related quality of life in individuals with prolonged symptoms following COVID-19 infection.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 4, 2023

Completed
Same day until next milestone

Study Start

First participant enrolled

January 4, 2023

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 9, 2023

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2024

Completed
Last Updated

January 13, 2026

Status Verified

July 1, 2025

Enrollment Period

1.4 years

First QC Date

January 4, 2023

Last Update Submit

January 9, 2026

Conditions

Keywords

Qigong

Outcome Measures

Primary Outcomes (1)

  • Changes in physical and mental health

    Changes in PROMIS-29 summary scores from before to after intervention in all participants

    8 weeks

Study Arms (2)

Immediate

EXPERIMENTAL

Receives 6 sessions of qigong first.

Behavioral: Qigong

Waitlist Control

OTHER

Receives 6 sessions of qigong after the immediate group

Behavioral: Qigong

Interventions

QigongBEHAVIORAL

6 sessions of combined external and internal qigong delivered in a group-based format once a week.

ImmediateWaitlist Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • English-speaking adults age 18 or greater
  • History of a COVID-19 infection with lingering symptoms lasting longer than 12 weeks
  • Willing and able to access the internet to complete questionnaires
  • Willing and able to travel to the qigong sessions to participate in person in Sacramento, CA.

You may not qualify if:

  • Lung scarring secondary to COVID-19 infection as evidenced by signs of parenchymal lung damage on imaging or FVC \< 80% (any patient with post COVID-related shortness of breath must have PFTs to be considered for enrollment).
  • Dementia
  • Any other condition that makes it difficult for the individual to complete questionnaires or attend the qigong sessions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California Davis Health

Sacramento, California, 95817, United States

Location

Related Publications (1)

  • Joy M, Adams N, Yanuck M, Dossett ML. Experiences with Qi and changes in post-acute sequelae of COVID-19 (PASC) symptoms with qigong: a qualitative analysis of participants' experiences in a pilot clinical trial. BMC Complement Med Ther. 2025 Nov 28;25(1):434. doi: 10.1186/s12906-025-05161-w.

MeSH Terms

Conditions

Post-Acute COVID-19 Syndrome

Interventions

Qigong

Condition Hierarchy (Ancestors)

COVID-19Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesPost-Infectious DisordersChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Breathing ExercisesMind-Body TherapiesComplementary TherapiesTherapeuticsExercise Movement TechniquesPhysical Therapy Modalities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized, waitlist controlled design
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor in Residence

Study Record Dates

First Submitted

January 4, 2023

First Posted

January 9, 2023

Study Start

January 4, 2023

Primary Completion

May 15, 2024

Study Completion

May 15, 2024

Last Updated

January 13, 2026

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Must submit written request and complete data sharing agreement.

Locations